High antibody prevalence in an unconventional ecosystem is related to circulation of a low-virulent strain of Japanese encephalitis virus

Vaccine

Volumn 25, Issue 8, 2007, Pages 1437-1443

  Chiou, Shyan Song ^a,b   Tsai, Kun Hsien ^b   Huang, Chin Gi ^b   Liao, Yung Kung ^c   Chen, Wei June ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

Japanese encephalitis virus; Natural vaccine; Virus virulence

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ECOSYSTEM; GENETIC TRAIT; HUMAN; JAPANESE ENCEPHALITIS VIRUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TAIWAN; VERO CELL; VIRUS STRAIN; VIRUS VIRULENCE;

ADULT; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CERCOPITHECUS AETHIOPS; CULICIDAE; ECOSYSTEM; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS; IMMUNOGLOBULIN M; MIDDLE AGED; PREVALENCE; TAIWAN; VERO CELLS; VIRUS REPLICATION;

EID: 33846053072     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.10.044     Document Type: Article

References (35)

1. Vaughn D.W., and Hoke Jr. C.H. The epidemiology of Japanese encephalitis: prospects for prevention. Am J Epidemiol 14 (1992) 197-221
2. Igarashi A. Epidemiology and control of Japanese encephalitis. World Health Stat Q 45 (1992) 299-305
3. CDC. Inactivated Japanese encephalitis virus vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 42 (1993) 1-15
4. Brandt W.E. Development of dengue and Japanese encephalitis vaccines. J Infect Dis 162 (1990) 577-583
5. Halstead S.B., and Grosz C.R. Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea. Am J Hyg 75 (1962) 190-201
6. Grossman R.A., Edelman R.E., Willhight M., Pantuwatana S., and Udomsakdi S. Study of Japanese encephalitis virus in Chiangmai valley, Thailand. III. Human seroepidemiology and inapparent infections. Am J Epidemiol 98 (1973) 133-149
7. Benenson M.W., Top F.H., Gresso W., Ames C.W., and Altstatt L.B. The virulence to man of Japanese encephalitis virus in Thailand. Am J Trop Med Hyg 24 (1975) 974-980
8. Chakraborty M.S., Chakravarti S.K., Mukherjee K.K., and Mitra A.C. Inapparent infection by Japanese encephalitis (JE) virus in West Bengal. Ind J Pub Health 24 (1980) 121-127
9. Huang C.H. Studies of Japanese encephalitis in China. Adv Virus Res 27 (1982) 71-101
10. Edelman R., Schneider R.J., Chiewanich P., Pornpibul R., and Voodhikul P. The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J Trop Med Pub Health 6 (1975) 308-315
11. Putvatana R., Yoksan S., Chayayodhin T., Bhamarapravati N., and Halstead S.B. Absence of dengue 2 infection enhancement in human sera containing Japanese encephalitis antibodies. Am J Trop Med Hyg 33 (1984) 288-294
12. Miura K., Onodera T., Nishida A., Goto N., and Fujisaki Y. A single gene controls resistance to Japanese encephalitis in mice. Arch Virol 112 (1990) 261-270
13. Ogata A., Nagashima K., Hall W.W., Ichikawa M., Kimura-Kuroda J., and Yasui K. Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. J Virol 65 (1991) 880-886
14. Morris J.A., O'Connor J.R., and Smadel J.E. Infection and immunity patterns in monkeys injected with viruses of Russian spring-summer and Japanese encephalitis. Am J Hyg 62 (1955) 327-341
15. Wu Y.C., Huang Y.S., Chien L.J., Lin T.L., Yueh Y.Y., Tseng W.L., et al. The epidemiology of Japanese encephalitis on Taiwan during 1966-1997. Am J Trop Med Hyg 61 (1999) 78-84
16. Yang S.E., Pan M.J., Tseng H.F., and Liau M.Y. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine-results from 30 years experience in Taiwan. Vaccine 24 (2006) 2669-2673
17. Shyu W.R., Wang Y.C., Chin C., and Chen W.J. Assessment of neutralizing antibodies elicited by a vaccine (Nakayama) strain of Japanese encephalitis virus in Taiwan. Epidemiol Infect 119 (1997) 79-83
18. Marfin A.A., and Gubler D.J. Japanese encephalitis: the need for a more effective vaccine. Lancet 366 (2005) 1335-1337
19. Bista M.B., Banerjee M.K., Shin S.H., Tandan J.B., Kim M.H., Sohn Y.M., et al. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358 (2001) 791-795
20. Ohrr H., Tandan J.B., Sohn Y.M., Shin S.H., Pradhan D.P., and Halstead S.B. Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study. Lancet 366 (2005) 1375-1378
21. Chen W.J., Dong C.F., Chiou L.Y., and Chuang W.L. Potential role of Armigeres subalbatus (Diptera: Culicidae) in the transmission of Japanese encephalitis virus in the absence of rice culture on Liu-Chiu islet, Taiwan. J Med Entomol 37 (2000) 108-113
22. Ku, CC., The vaccine evaluation and seroepidemiology of Japanese encephalitis in Taiwan (1990-1992). 1992. M.S. thesis. National Taiwan University, Taipei, Taiwan.
23. Chiou S.S., and Chen W.J. Mutations in the NS3 gene and 3′-NCR of Japanese encephalitis virus isolated from an unconventional ecosystem and implications for natural attenuation of the virus. Virology 289 (2001) 129-136
24. Russell P.K., and Nisalak A. Dengue virus identification by the plaque reduction neutralization test. J Immunol 99 (1967) 291-296
25. Chen W.J., Hwang K.P., and Fang A.H. Detection of IgM antibodies from cerebrospinal fluid and sera of dengue fever patients. Southeast Asian J Trop Med Pub Health 22 (1991) 659-663
26. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319 (1988) 608-614
27. WHO. Global Advisory Committee on Vaccine Safety, 9-10 June 2005. Wkly Epidemiol Rec 80 (2005) 242-243
28. Anzala A.O., Nagelkerke N., Bwayo J.J., Holton D., Moses S., Ngugi E.N., et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 171 (1995) 686-689
29. Groseth A., Stroher U., Theriault S., and Feldmann H. Molecular characterization of an isolate from the 1989/90 epizootic of Ebola virus Reston among macaques imported into the United States. Virus Res 87 (2002) 155-163
30. Sohn Y.M., Park M.S., Rho H.O., Chandler L.J., Shope R.E., and Tsai T.F. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine 17 (1999) 2259-2264
31. Chen H.W., Pan C.H., Liau M.Y., Jou R., Tsai C.J., Wu H.J., et al. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 73 (1999) 10137-10145
32. Ni H., Chang G.J., Xie H., Trent D.W., and Barrett A.D. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J Gen Virol 76 (1995) 409-413
33. Pircher H., Moskophidis D., Rohrer U., Burki K., Hengartner H., and Zinkernagel R.M. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346 (1990) 629-633
34. Ni H., and Barrett A.D. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants. Virology 241 (1998) 30-36
35. Macadam A.J., Ferguson G., Stone D.M., Meredith J., Almond J.W., and Minor P.D. Live-attenuated strains of improved genetic stability. Dev Biol 105 (2001) 179-187